For Those Who Seek Treatment at Kobe University Hospital

Advanced Medical Treatment

At Kobe University Hospital, we provide the following types of advanced medical care. If you would like to know about these options in more detail, please ask the clinical department which offers the treatment you want.

Most of the medical insurance policies do not cover these advanced medical treatments, since such policies are only for common treatment, examination, and medication. Please understand that advanced medical treatments are not subject to health insurance or major medical expense coverage.

The treatments listed below are approved by the Ministry of Health, Labour and Welfare. (as of January 1st, 2018)

Genetic diagnosis of familial Alzheimer's disease

Indications:Familial Alzheimer's Disease

Clinical department:Neuropsychiatry

Advanced medical fee: 62,400 yen per diagnosis

DNA testing for drug resistant gene in case of chemotherapy

Indications:Malignant brain tumor

Clinical department: Neurosurgery

Advanced medical fee: 54,900 yen per test

Remission maintenance therapy by oral administration of mycophenolate mofetil after intravenous infusion of rituximab

Indications:Complicated idiopathic nephrotic syndrome (limited to patients who are with frequently relapsing or steroid dependent nephrotic syndrome and were less than 18 years old at the time of the emergence of the symptoms)

Clinical Department: Pediatrics

Advanced medical fee: 46,400 yen per one sequence of the treatment

Angiogenesis therapy with beperminogene perplasmid(This treatment is not available now)

Indications:obstructive arteriosclerosis or Burger disease (limited to patients with symptoms difficult to treat with revascularization and intravascular treatment and are Fontan classification III or IV degree)

Clinical Department: Cardiovascular Medicine

Advanced medical fee: 0 yen per series of treatment

Combination therapy of oral temozolomide administration and radiation therapy after high-dose methotrexate therapy prior to radiation and maintenance therapy with oral administration of temozolomide

Indications:primary central nervous system lymphoma (limited to those which are confirmed to be diffuse large B-cell lymphoma from the pathological standpoint and whose primary sites are the cerebrum, cerebellum or brainstem)

Clinical Department: Neurosurgery

Advanced medical fee: 84,156yen per treatment

Perioperative venous dosage of carperitide with reccurence prevetion therapy

Indications:small cell lung cancer (except for those diagnosed as non-invasive cancer by CT imaging)

Clinical Department: Thoracic Surgery

Advanced medical fee: 1,610 yen per treatment

Preoperative chemotherapy with trastuzumab combined with S-1 plus cisplatin

Indications:removable gastric cancer with expansive lymph node metastasis (limited to HER2 positive cancer)

Clinical Department: Division of Gastrointesinal Surgery, Department of Surgery

Advanced medical fee: 22,934 yen per one sequence of the therapy

Mitral valve replacement using autologus pericardium annuloplasty

Indications:mitral insufficiency(patients with both flaps of mitral valves destoyed due to infectious endocarditis or those who received mitral vulvuloplasty more than 6 months ago from the day of the operation with approval of re-operation

Clinical Department: Cardiovascular Surgery

Advanced medical fee: 440,132yen per one sequence of treatment

Dose-dense temozolomide therapy

Indications:Glioblastoma

Clinical Department: Neurosurgery

Advanced medical fee: 1,943 yen per dose

Multifocal intraocular lens implantation in cataract surgery

Indications:Cataract

Clinical Department: Ophthalmology

Advanced medical fee: 309,532 yen per surgery

Other state-of-the-art medical treatment

In addition to the advanced technologies shown above which are approved by the Ministry of Health, Labour and Welfare, we also provide other cutting-edge medical care. For details please call in directlyto the relevant clinical department

top of page